What SEC filings does Viemed Healthcare, Inc. submit to the SEC?

Viemed Healthcare, Inc. (VMD) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about VMD?

A Form 4 for VMD discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the source-reported date, number of shares, price, and updated ownership. These facts do not establish motive or predict future returns.

How do I interpret an 8-K filing from Viemed Healthcare, Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for VMD?

The 10-K is Viemed Healthcare, Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all VMD SEC filings directly on EDGAR?

You can view all historical Viemed Healthcare, Inc. filings on the SEC EDGAR company page for VMD. Each filing card on this page links directly to the original SEC document.

How often does Viemed Healthcare, Inc. file with the SEC?

Viemed Healthcare, Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling VMD shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

VMD SEC Filing News — Viemed Healthcare, Inc.

Latest SEC filings for Viemed Healthcare, Inc. (VMD) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-08-20.

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and ren…

Sector: Healthcare Industry: Medical Devices Market Cap: $365.3M CIK: 1729149

Total Filings

Bullish Classifications

Bearish Classifications

Insider Transactions

Material Events (8-K)

Periodic Reports

Rule-based classifications for VMD currently lean bearish. Of the 20 filing records displayed, 3 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.

VMD Filing Activity Snapshot 2026-03-04 — 2026-08-20

Insider Transactions (Form 4)

0 buys vs 3 sells

Net insider selling in this period — insiders sell for many reasons beyond conviction.

Largest Form 144 Filing

$1.24M

Moore Michael (President) · 2026-03-20

136,802 shares · Form 4

Form 144 Notices

Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.

Insider Transactions 7 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 7 filings in this group are Form 4s for Viemed Healthcare, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 7 insider filings shown, the breakdown is 4 compensation award and 3 open-market sale. 3 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Compensation award ×4: Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Open-market sale ×3: The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Form 4 Compensation award Tax / Compensation Filing 2026-08-19

VMD insider Form 4 filed for equity award, exercise, or tax withholding

Kaushal Nitin (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	18,786	—	—
`M`	Option exercise derivative · Restricted Stock Units	18,786	—	—
`A`	Compensation award derivative · Restricted Stock Units	15,217	—	—

Filing: Form 4 (Insider Transaction) Insider: Kaushal Nitin (Director) Shares: 18,786

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-08-19

VMD insider Form 4 filed for equity award, exercise, or tax withholding

Heltz Sabrina (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	15,029	—	—
`M`	Option exercise	3,757	—	—
`D`	Disposition to issuer	3,757	$8.94	$33.6K
`M`	Option exercise derivative · Restricted Stock Units	15,029	—	—
`M`	Option exercise derivative · Phantom Share Units	3,757	—	—
`A`	Compensation award derivative · Restricted Stock Units	12,174	—	—
`A`	Compensation award derivative · Phantom Share Units	3,043	—	—

Filing: Form 4 (Insider Transaction) Insider: Heltz Sabrina (Director) Shares: 22,543

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-08-19

VMD insider Form 4 filed for equity award, exercise, or tax withholding

Dobbs Randy E. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	16,763	—	—
`M`	Option exercise	4,191	—	—
`D`	Disposition to issuer	4,191	$8.94	$37.5K
`M`	Option exercise derivative · Restricted Stock Units	16,763	—	—
`M`	Option exercise derivative · Phantom Share Units	4,191	—	—
`A`	Compensation award derivative · Restricted Stock Units	16,848	—	—

Filing: Form 4 (Insider Transaction) Insider: Dobbs Randy E. (Director) Shares: 25,145

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-08-19

VMD insider Form 4 filed for equity award, exercise, or tax withholding

Smokoff Timothy (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	15,029	—	—
`M`	Option exercise	3,757	—	—
`D`	Disposition to issuer	3,757	$8.94	$33.6K
`M`	Option exercise derivative · Restricted Stock Units	15,029	—	—
`M`	Option exercise derivative · Phantom Share Units	3,757	—	—
`A`	Compensation award derivative · Restricted Stock Units	12,174	—	—
`A`	Compensation award derivative · Phantom Share Units	3,043	—	—

Filing: Form 4 (Insider Transaction) Insider: Smokoff Timothy (Director) Shares: 22,543

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-06-26

VMD insider Frazier William (Director, Chief Medical Officer) sold 10,000 shares (~$117.2K)

Frazier William, listed as Director, Chief Medical Officer at VIEMED HEALTHCARE, INC., reported an open-market sale of 10,000 VMD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	10,000	$1.81	$18.1K
`S`	Open-market sale	10,000	$11.72	$117.2K
`M`	Option exercise derivative · Stock Options	10,000	—	—

Filing: Form 4 (Insider Transaction) Insider: Frazier William (Director, Chief Medical Officer) Shares: 10,000 Est. Value: $117.2K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-06-26

VMD insider Smokoff Timothy (Director) sold 20,000 shares (~$230.0K)

Smokoff Timothy, listed as Director at VIEMED HEALTHCARE, INC., reported an open-market sale of 20,000 VMD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	1,636	$11.48	$18.8K
`S`	Open-market sale	3,364	$11.50	$38.7K
`S`	Open-market sale	5,000	$11.56	$57.8K
`S`	Open-market sale	5,000	$11.53	$57.6K
`S`	Open-market sale	5,000	$11.41	$57.0K

Filing: Form 4 (Insider Transaction) Insider: Smokoff Timothy (Director) Shares: 20,000 Est. Value: $230.0K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-03-20

VMD insider Moore Michael (President) sold 136,802 shares (~$1.24M)

Moore Michael, listed as President at VIEMED HEALTHCARE, INC., reported an open-market sale of 136,802 VMD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	31,570	$9.42	$297.4K
`S`	Open-market sale	40,232	$9.21	$370.5K
`S`	Open-market sale	65,000	$8.77	$570.0K

Filing: Form 4 (Insider Transaction) Insider: Moore Michael (President) Shares: 136,802 Est. Value: $1.24M

View on SEC EDGAR → Open Filing Document →

Proposed Insider Sales 3 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Viemed Healthcare, Inc. has 3 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-03-20

VMD Form 144 filed for proposed insider sale by MOORE FASTER LLC (65,000 shares) ~$570.1K

MOORE FASTER LLC filed a Form 144 with the SEC indicating intent to sell VMD (VIEMED HEALTHCARE, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: MOORE FASTER LLC Shares: 65,000 Est. Value: $570.1K

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-03-19

VMD Form 144 filed for proposed insider sale by MOORE FASTER LLC (40,232 shares) ~$370.4K

Filing: Form 144 (Proposed Sale Notice) Insider: MOORE FASTER LLC Shares: 40,232 Est. Value: $370.4K

View on SEC EDGAR → Open Filing Document →

Form 144 Proposed Insider Sale 2026-03-18

VMD Form 144 filed for proposed insider sale by MOORE FASTER LLC (31,570 shares) ~$297.3K

Filing: Form 144 (Proposed Sale Notice) Insider: MOORE FASTER LLC Shares: 31,570 Est. Value: $297.3K

View on SEC EDGAR → Open Filing Document →

Material Events 7 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 7 in this period for Viemed Healthcare, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-08-20